Research Newsletter

Dr. Timothy L. Ratliff New Director at Purdue Cancer Center

Dr. Timothy L. Ratliff’s appointment as the director of the Purdue Cancer Center will begin July 1, 2007. He will also have an appointment as professor of comparative pathobiology in the School of Veterinary Medicine.

“Dr. Ratliff is an outstanding scientist with a many-year history of translational research,” says Dr. Stephen D. Williams, IU Cancer Center director and School of Medicine dean of cancer research.“I was honored to serve on the search committee and look forward to working with Dr. Ratliff as we expand the collaborations between our cancer centers.”

Dr. Ratliff received his bachelor’s of science degree in biology and chemistry while studying at the University of Texas, Arlington. He went on to receive his master’s degree in biology at Texas A&M, Commerce and his Ph.D. in microbiology at the University of Arkansas. Dr. Ratliff has been at the University of Iowa since 1997 and was involved in immunotherapy studies using prostate and bladder cancer models. These studies address questions regarding activation of antitumor responses, characterization of antitumor effector mechanisms, and the regulation of antitumor immunity. Most recently he served as the research vice chair of the Department of Urology.

The Purdue Cancer Center is among an elite group of cancer centers nationwide to earn the distinguished National Cancer Institute (NCI) designation. As one of just seven NCI-designated basic research cancer centers in the United States, Purdue Cancer Center is committed to helping cancer patients by identifying new molecular targets and designing future agents and drugs for effectively detecting and treating cancer.